Advertisement
GE Healthcare
GE Healthcare

The Scientist

» Big Pharma and developmental biology

Most Recent

image: J&J to Share Trial Data

J&J to Share Trial Data

By | January 31, 2014

The pharmaceutical giant teams up with Yale University to make raw clinical data available to researchers.

0 Comments

image: Fish of Many Colors

Fish of Many Colors

By | January 23, 2014

Researchers seek insight into the pigmentation patterns of guppies and zebrafish.

0 Comments

image: Week in Review: January 6–10

Week in Review: January 6–10

By | January 10, 2014

Bacterial genes aid tubeworm settling; pigmentation of ancient reptiles; nascent neurons and vertebrate development; exploring simple synapses; slug-inspired surgical glue

0 Comments

image: UK Government Laments Tamiflu Secrets

UK Government Laments Tamiflu Secrets

By | January 6, 2014

A parliamentary committee says drugmakers have not disclosed enough data on the anti-influenza medicine.

0 Comments

image: Thomas Gregor: Biological Quantifier

Thomas Gregor: Biological Quantifier

By | November 1, 2013

Assistant Professor, Physics, Princeton University. Age: 39

0 Comments

image: About Face

About Face

By | October 25, 2013

Researchers show that genetic enhancer elements likely contribute to face shape in mice.

0 Comments

image: Bacterial Quid Pro Quo

Bacterial Quid Pro Quo

By | August 19, 2013

Pseudomonas aeruginosa gather swarming speed at the expense of their ability to form biofilms in an experimental evolution setup.

0 Comments

image: Stem Cells Open Up Options

Stem Cells Open Up Options

By | August 13, 2013

Pluripotent cells can help regenerate tissues and maintain long life—and they may also help animals jumpstart drastically new lifestyles.

17 Comments

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

Advertisement

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  4. Four-legged Snake Fossil Found
Advertisement
Advertisement